2nd Affiliated Hospital, School of Medicine, Zhejiang University
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effects of Agent-assisted, LLM-assisted and Traditional Workflows on Diagnosis and Management Planning at Admission | Artificial Intelligence (AI); Clinical Decision Support Systems; Diagnostic Reasoning | Recruiting | Not applicable | 2026-09-28 | NCT07760051 | |
| Efficacy and Safety of Culmerciclib Plus Aromatase Inhibitors in a Response-Adapted Neoadjuvant Strategy for Highly Proliferative ER-Positive/HER2-Negative Breast Cancer | HR+/HER2- Early Breast Cancer | Recruiting | Phase 2 | 2026-06-01 | NCT07616453 | |
| Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenocarcinoma, carcinoma, disease, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Not stated | 2026-05-27 | NCT06544083 | |
| Specific Dietary Pattern for Crohn's Disease Patients Following Surgery | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Not applicable | 2026-02-02 | NCT05502965 | |
| AI-assisted Diagnosis of Malignant Brain Tumors | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Not stated | 2025-09-30 | NCT07198256 | |
| Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma | Primary Central Nervous System Hodgkin Lymphoma | Recruiting | Phase 2 | 2025-07-31 | NCT04961515 | |
| Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm | Recruiting | Not stated | 2025-02-06 | NCT06718257 | |
| Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mature T-cell and NK-cell non-Hodgkin lymphoma, neoplasm | Recruiting | Phase 2 | 2022-11-07 | NCT04922567 |